3rd Jul 2023 09:07
(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.
Read more17th Mar 2023 08:57
(Sharecast News) - Molecular diagnostic group Yourgene Health revealed on Friday that chief financial officer Barry Hextall will step down from his role, with immediate effect.
Read more3rd Nov 2022 12:09
(Sharecast News) - Molecular diagnostics specialist Yourgene said in a trading update on Thursday that its first-half core revenues were up 14% year-on-year at £8m.
Read more17th Feb 2022 15:21
(Sharecast News) - Molecular diagnostic company Yourgene has received confirmation from the UK Health Security Agency that the 'Clarigene' SARS-CoV-2 test has been approved under the requirements set out in the Coronavirus Test Device Approvals regulations, it announced on Thursday.
Read more17th Jan 2022 12:06
(Sharecast News) - Molecular diagnostic company Yourgene Health said on Monday that full-year earnings and revenues will exceed expectations after the strong trading performance delivered by the group in the first half of the year continued into the second.
Read more23rd Dec 2021 09:02
(Sharecast News) - Molecular diagnostics group Yourgene has been awarded a contract to provide laboratory capacity to the Department of Health & Social Care in order to support a Winter surge in Covid-19 testing.
Read more26th Oct 2021 10:20
(Sharecast News) - Molecular diagnostics group Yourgene Health said on Tuesday that interim revenues grew strongly to £17.5m, more than double the £8.2m recorded in the prior year and ahead of previous guidance of £15.0m.
Read more18th Jun 2021 09:17
(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.
Read more9th Jun 2021 09:58
(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.
Read more26th Apr 2021 10:56
(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.
Read more19th Apr 2021 08:49
(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.
Read more8th Feb 2021 09:13
(Sharecast News) - Molecular diagnostics group Yourgene Health said on Monday that while some strong second-half momentum was expected to deliver double-digit annual growth, the improvement was now seen printing below prior expectations.
Read more24th Dec 2020 09:49
(Sharecast News) - Molecular diagnostics company Yourgene Health announced on Thursday that Yourgene Genomic Services had been added to the UK government's approved Covid-19 private testing providers list for the 'Test to Release for International Travel' scheme introduced on 15 December, and also for general coronavirus testing.
Read more26th Oct 2020 10:02
(Sharecast News) - Molecular diagnostics group Yourgene Health said on Monday that interim revenues had risen as a strong showing from its European unit had offset much of the headwinds stemming from the Covid-19 pandemic.
Read more21st Sep 2020 08:16
(Sharecast News) - Molecular diagnostics company Yourgene has appointed Immuno-Biological Laboratories, a supplier of in-vitro diagnostic kits for the medical device and research industry, as a non-exclusive distributor for several polymerase chain reaction (PCR) tests across its reproductive health and oncology portfolios in the United States, it announced on Monday.
Read more